Returns Breakdown
| Return on Investment | (8.74) | |
| Return on Assets | (0.25) | |
| Return on Equity | (0.31) | |
| Return Capital | (0.12) | |
| Return on Sales | (0.0563) |
Estimating Iridex Cp (NASDAQ:IRIX) price for April 2021.
 | By Vlad Skutelnik | Macroaxis Story |
Iridex Cp Asset Turnover is fairly stable at the moment as compared to the past year. Iridex Cp reported Asset Turnover of 0.94 in 2020. Debt to Equity Ratio is likely to rise to 0.26 in 2021, whereas Net Income Per Employee is likely to drop (90 K) in 2021. The basic goal of this article is to give investors our perspective on Iridex for April. We will forecast Iridex Cp value for investors.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Gabriel Shpitalnik
This firm has a beta of 0.3312. Let's try to break down what Iridex's beta means in this case. Iridex Cp returns are very sensitive to returns on the market. As the market goes up or down, Iridex Cp is expected to follow. The beta indicator helps investors understand whether Iridex Cp moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Iridex deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as IRIDEX. Your research has to be compared to or analyzed against IRIDEX's peers to derive any actionable benefits. When done correctly, IRIDEX's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in IRIDEX.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as IRIDEX. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Predictive Modules for IRIDEX
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IRIDEX's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
How important is IRIDEX's Liquidity
IRIDEX financial leverage refers to using borrowed capital as a funding source to finance IRIDEX ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. IRIDEX financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to IRIDEX's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of IRIDEX's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between IRIDEX's total debt and its cash.
IRIDEX Gross Profit
IRIDEX Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing IRIDEX previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show IRIDEX Gross Profit growth over the last 10 years. Please check IRIDEX's gross profit and other fundamental indicators for more details.
Breaking down the case for IRIDEX
Iridex Cp is displaying above-average volatility over the selected time horizon. Investors should scrutinize Iridex Cp independently to ensure intended market timing strategies are aligned with expectations about Iridex Cp volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Iridex Cp's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Iridex Cp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of IRIDEX. Please refer to our Terms of Use for any information regarding our disclosure principles.